I personally don't believe AZ is working on dep-docetaxel with SPL.
I think the game plan for SPL is to churn out a quick (haha) Phase 2, maybe 12-18 months for the indications they desire, and own all the data post Phase 2. I think at that juncture they will then choose to license dep-docetaxel for the Phase 3.
I would much prefer them to take it all the way to market themselves, but at this point in time, they simply don't have the resources to do so.
I personally don't believe AZ is working on dep-docetaxel with...
-
- There are more pages in this discussion • 10 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add SPL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
10.0¢ |
Change
-0.005(4.76%) |
Mkt cap ! $43.29M | |||
| Open | High | Low | Value | Volume |
| 10.0¢ | 10.0¢ | 10.0¢ | $430 | 4.302K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 10698 | 10.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 10.5¢ | 128856 | 4 |
View Market Depth
| Last trade - 10.12am 12/07/2024 (20 minute delay) ? |
| SPL (ASX) Chart |